Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (vol 4, e002015, 2015)

被引：1
|
作者：
Rao, M. P.
机构：
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 04期
关键词：
D O I：
10.1161/JAHA.119.014653
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
    Garcia, David A.
    Wallentin, Lars
    Lopes, Renato D.
    Thomas, Laine
    Alexander, John H.
    Hylek, Elaine M.
    Ansell, Jack
    Hanna, Michael
    Lanas, Fernando
    Flaker, Greg
    Commerford, Patrick
    Xavier, Denis
    Vinereanu, Dragos
    Yang, Hongqiu
    Granger, Christopher B.
    [J]. AMERICAN HEART JOURNAL, 2013, 166 (03) : 549 - 558
  • [12] History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
    De Caterina, Raffaele
    Andersson, Ulrika
    Alexander, John H.
    Al-Khatib, Sana M.
    Bahit, M. Cecilia
    Goto, Shinya
    Hanna, Michael
    Held, Claes
    Hohnloser, Stefan
    Hylek, Elaine M.
    Lanas, Fernando
    Lopes, Renato D.
    Lopez-Sendon, Jose
    Renda, Giulia
    Horowitz, John
    Granger, Christopher B.
    Wallentin, Lars
    [J]. AMERICAN HEART JOURNAL, 2016, 175 : 175 - 183
  • [13] Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale (vol 159, pg 331, 2010)
    Pinto, D. J.
    Orwat, M. J.
    Koch, S.
    [J]. AMERICAN HEART JOURNAL, 2010, 159 (06)
  • [14] APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL
    Cowper, Patricia A.
    Pan, Wenqin
    Anstrom, Kevin
    Stafford, Judith
    Lopes, Renato
    Davidson-Ray, Linda
    Wallentin, Lars
    Phatak, Hemant
    Ansell, Jack
    Dorian, Paul
    Husted, Steen
    McMurray, John
    Steg, P. Gabriel
    Alexander, John
    Granger, Christopher
    Mark, Daniel
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1576 - E1576
  • [15] Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Wallentin, Lars
    Hijazi, Ziad
    Andersson, Ulrika
    Alexander, John H.
    De Caterina, Raffaele
    Hanna, Michael
    Horowitz, John D.
    Hylek, Elaine M.
    Lopes, Renato D.
    Asberg, Signild
    Granger, Christopher B.
    Siegbahn, Agneta
    [J]. CIRCULATION, 2014, 130 (21) : 1847 - +
  • [16] Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Granger, Christopher B.
    Lopes, Renato D.
    Hanna, Michael
    Ansell, Jack
    Hylek, Elaine M.
    Alexander, John H.
    Thomas, Laine
    Wang, Junyuan
    Bahit, M. Cecilia
    Verheugt, Freek
    Lawrence, Jack
    Xavier, Denis
    Wallentin, Lars
    [J]. AMERICAN HEART JOURNAL, 2015, 169 (01) : 25 - 30
  • [17] POORLY CONTROLLED BLOOD PRESSURE IS INDEPENDENTLY ASSOCIATED WITH A 50% HIGHER RISK OF STROKE OR SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL
    Rao, Meena
    Halvorsen, Sigrun
    Wojdyla, Daniel
    Alexander, John
    Lopes, Renato
    Hylek, Elaine
    Hanna, Michael
    Bahit, Maria
    De Caterina, Raffaele
    Erol, Cetin
    Goto, Shinya
    Lanas, Fernando
    Lewis, Basil
    Husted, Steen
    Wallentin, Lars
    Granger, Christopher
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A362 - A362
  • [18] Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial fibrillation: results from the ARISTOTLE Trial
    Flaker, G.
    Lopes, R.
    Al-Khatib, S.
    Hermosillo, A.
    Thomas, L.
    Zhu, J.
    Ruzyllo, W.
    Mohan, P.
    Granger, C.
    Wallentin, L.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 686 - 686
  • [19] Blood Pressure Control and Stroke or Bleeding Risk in Patients with Atrial Fibrillation: Results from the ROCKET AF Trial
    Vemulapalli, Sreekanth
    Hellkamp, Anne S.
    Jones, W. Schuyler
    Piccini, Jonathan P.
    Mahaffey, Kenneth W.
    Becker, Richard C.
    Hankey, Graeme J.
    Berkowitz, Scott D.
    Breithardt, Guenter
    Singer, Daniel E.
    Fox, Keith A.
    Califf, Robert M.
    Patel, Manesh R.
    [J]. CIRCULATION, 2014, 130
  • [20] Apixaban: A Review of its Use for Reducing the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation
    Gillian M. Keating
    [J]. Drugs, 2013, 73 : 825 - 843
12345